Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the ...

The Phase 1 trial of the mRNA vaccine candidate will assess safety, determine the dosage range and identify potential side ...

Moderna begins Ebola vaccine trials in Canada for Bundibugyo strain. Phase 1 assesses safety, dosage, and side effects.

If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine.

Health Canada has approved a Phase 1 clinical trial for Moderna's potential mRNA vaccine for the Bundibugyo strain of Ebola.

BUNIA, Congo (AP) — Wiza Bondele goes to work every day at a hospital in Congo with one goal in mind: to slow the ...

TORONTO — Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of ...

Moderna began a Phase 1 clinical trial of its experimental vaccine mRNA-1469 targeting the Bundibugyo strain of Ebola virus.

The program is backed by the Coalition for Epidemic Preparedness Innovations, which has committed up to $50 million.

Canada's chief science adviser says the federal government should devise a way to reflect on its response to the COVID-19 pandemic to better prepare the country and Canadians for future public health ...

Ottawa is launching a temporary ban on foreign nationals entering Canada if they have visted DRC, the site of an ebola outbreak, 21 days before coming to this country.